Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

April 30, 2007

Conditions
Cocaine-Related DisordersOpiate Dependence
Interventions
DRUG

Tiagabine

The tiagabine group will start receiving tiagabine 4mg in the evening of the first day on week 2. The dose will be titrated every third day, until the target dose of 32mg/day is achieved by week 5. The study medication must be titrated to 32 mg/day or to the subject's maximum tolerated dose (MTD).

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00129298 - Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 | Biotech Hunter | Biotech Hunter